OncoSec Medical Incorporated (ONCSQ)

OncoSec Medical Statistics

Total Valuation

OncoSec Medical has a market cap or net worth of 6.

Market Cap	6
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

OncoSec Medical has 5.96 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	5.96M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+44.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.31%
Float	5.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.89

Current Ratio	0.89
Quick Ratio	0.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.34
Interest Coverage	-626.33

Financial Efficiency

Return on equity (ROE) is -410.17% and return on invested capital (ROIC) is -119.93%.

Return on Equity (ROE)	-410.17%
Return on Assets (ROA)	-92.84%
Return on Capital (ROIC)	-119.93%
Revenue Per Employee	n/a
Profits Per Employee	-716,728
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-17.99
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	0.00
Relative Strength Index (RSI)	48.06
Average Volume (20 Days)	3,041

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.65M
Pretax Income	-32.72M
Net Income	-29.39M
EBITDA	-32.40M
EBIT	-32.65M
Earnings Per Share (EPS)	-14.77

Balance Sheet

The company has 3.68 million in cash and 8.46 million in debt, giving a net cash position of -4.78 million or -0.80 per share.

Cash & Cash Equivalents	3.68M
Total Debt	8.46M
Net Cash	-4.78M
Net Cash Per Share	-0.80
Equity (Book Value)	-5.49M
Book Value Per Share	-1.85
Working Capital	-789,468

Cash Flow

In the last 12 months, operating cash flow was -24.99 million and capital expenditures -15,955, giving a free cash flow of -25.01 million.

Operating Cash Flow	-24.99M
Capital Expenditures	-15,955
Free Cash Flow	-25.01M
FCF Per Share	-4.19

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OncoSec Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.17%
Shareholder Yield	-13.17%
Earnings Yield	-1,477,410,900.00%
FCF Yield	-419,451,864.71%

Stock Splits

The last stock split was on November 9, 2022. It was a reverse split with a ratio of 0.0454545.

Last Split Date	Nov 9, 2022
Split Type	Reverse
Split Ratio	0.0454545

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a